Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
3.4 GBX
Market Closed
Updated:
May 15, 2024
Fusion Antibodies PLC
Net Issuance of Common Stock
|
Fusion Antibodies PLC
Net Issuance of Common Stock Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Net Issuance of Common Stock
£1.7m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Net Issuance of Common Stock
£71.6m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Net Issuance of Common Stock
£3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Net Issuance of Common Stock
£31k
|
CAGR 3-Years
-88%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Net Issuance of Common Stock
£305k
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Net Issuance of Common Stock
£521k
|
CAGR 3-Years
-69%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
See Also
What is Fusion Antibodies PLC's Net Issuance of Common Stock?
Net Issuance of Common Stock
1.7m
GBP
1.7m
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Net Issuance of Common Stock amounts to 1.7m GBP.
What is Fusion Antibodies PLC's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
-18%
-18%
Over the last year, the Net Issuance of Common Stock growth was 4 187%. The average annual Net Issuance of Common Stock growth rates for Fusion Antibodies PLC have been -16% over the past three years , -18% over the past five years .
You don't have any saved screeners yet
